Legal & General Group’s Dianthus Therapeutics DNTH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $34.1K | Sell |
1,829
-2,062
| -53% | -$38.4K | ﹤0.01% | 2807 |
|
2025
Q1 | $70.6K | Sell |
3,891
-8,428
| -68% | -$153K | ﹤0.01% | 2693 |
|
2024
Q4 | $269K | Buy |
12,319
+2,363
| +24% | +$51.5K | ﹤0.01% | 2626 |
|
2024
Q3 | $273K | Buy |
9,956
+1,902
| +24% | +$52.1K | ﹤0.01% | 2628 |
|
2024
Q2 | $207K | Buy |
+8,054
| New | +$207K | ﹤0.01% | 2660 |
|
2022
Q3 | – | Sell |
-2,389
| Closed | -$3K | – | 3464 |
|
2022
Q2 | $3K | Sell |
2,389
-691
| -22% | -$868 | ﹤0.01% | 3474 |
|
2022
Q1 | $9K | Hold |
3,080
| – | – | ﹤0.01% | 3422 |
|
2021
Q4 | $14K | Hold |
3,080
| – | – | ﹤0.01% | 3378 |
|
2021
Q3 | $22K | Hold |
3,080
| – | – | ﹤0.01% | 3242 |
|
2021
Q2 | $30K | Buy |
3,080
+823
| +36% | +$8.02K | ﹤0.01% | 3132 |
|
2021
Q1 | $27K | Sell |
2,257
-192
| -8% | -$2.3K | ﹤0.01% | 3021 |
|
2020
Q4 | $19K | Hold |
2,449
| – | – | ﹤0.01% | 3107 |
|
2020
Q3 | $17K | Sell |
2,449
-217
| -8% | -$1.51K | ﹤0.01% | 3019 |
|
2020
Q2 | $20K | Sell |
2,666
-627
| -19% | -$4.7K | ﹤0.01% | 3065 |
|
2020
Q1 | $21K | Sell |
3,293
-721
| -18% | -$4.6K | ﹤0.01% | 2888 |
|
2019
Q4 | $61K | Buy |
4,014
+765
| +24% | +$11.6K | ﹤0.01% | 2741 |
|
2019
Q3 | $33K | Hold |
3,249
| – | – | ﹤0.01% | 2916 |
|
2019
Q2 | $48K | Buy |
3,249
+810
| +33% | +$12K | ﹤0.01% | 2789 |
|
2019
Q1 | $40K | Buy |
2,439
+1,749
| +253% | +$28.7K | ﹤0.01% | 2787 |
|
2018
Q4 | $4K | Hold |
690
| – | – | ﹤0.01% | 3350 |
|
2018
Q3 | $8K | Buy |
+690
| New | +$8K | ﹤0.01% | 3342 |
|